In the bustling heart of Miami, amidst the buzz of the Benzinga Cannabis and Psychedelics Capital Conference, a pivotal conversation ignited a partnership destined to revolutionize the world of wellness.
Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist
Johns Hopkins University academics received a boost in funding thanks to the recently launched Roland R. Griffiths Ph.D. Professorship Fund.
Amanita Muscaria is the only kind of mushroom currently legal. As its health benefits are regularly being confirmed in studies, demand for related products is rapidly growing.
Delix Nabs 2 New Partners
Neuroscience company Delix Therapeutics is partnering with Sweden-based Cellectricon and New York-based Expressive Neuroscience.
The goal is to expedite Delix's drug development pipeline.
Health Canada Oks Clinical-Grade MDMA Export To UK
Life sciences psychedelics company PharmAla Biotech Holdings Inc. and its manufacturing partners received a Health Canada export permit for no less than 300 grams of proprietary MDMA LaNeo.
This article was originally published in December 2021.
Amanita Muscaria is an understudied species of psychoactive mushroom that’s as commonplace as it is misunderstood.